“They say nicotine has an antidepressant effect, so why do receptor blockers produce the same effect?
Isn’t that a contradiction?”
The moment you ask a dumb question like that, you prove you don’t even understand the basics of the system yet.
It’s proof you’re just a noob, barely at the level of memorizing drug names.
This field isn’t about belief.
Everything is a system. Everything is a mechanism.
If you don’t understand that, you’ll just be a slave, dragged around by drugs for the rest of your life.
The battlefield inside your skull has both infantry and snipers.
In our brain’s cholinergic system, the guy called acetylcholine is the basic infantry.
This guy isn’t picky, he just pokes everything—muscarinic, nicotinic receptors, doesn’t matter.
It’s called being non-selective.
But when there are too many of these infantry guys, meaning when acetylcholine levels get excessively high, mental breakdowns like depression occur.
In fact, there are reports that acetylcholinesterase inhibitors—drugs used for Alzheimer’s patients that block the enzyme breaking down acetylcholine, thereby increasing acetylcholine concentration in the brain—can induce depressive symptoms.
This is evidence supporting the cholinergic hypothesis: too much acetylcholine screws up your mental state.
That’s why antagonists that block cholinergic receptors have an antidepressant effect.
It’s like locking the door to block the attack of the excessive infantry.
So far, it’s simple and clear.
But then, a ridiculously funny situation arises.
Nicotine, that bastard, is different.
It’s a precision sniper.
It’s an agonist that specifically targets nicotinic receptors, yet it also produces an antidepressant effect.
Does that make any sense?
On one side, a shield (antagonist) that blocks the receptor protects your mental state, while on the other side, a spear (agonist) that directly smacks the receptor is said to do the same damn thing.
How can a spear and a shield produce the same result?
This is where minds get blown, and the line is drawn between those who understand the system and those who just memorize drug names.
The key is “receptor upregulation.”
If you don’t know this concept, you’ll be floundering in this swamp of contradiction forever.
The receptors in our body are like antennas.
They exist to receive signals.
If you keep blocking this antenna with an antagonist, the body goes, “Huh? Why aren’t the signals coming in?” and enters a state of emergency.
So it builds more antennas—more receptors.
It’s desperately trying to catch a signal somehow.
This is receptor upregulation caused by an antagonist.
Now, what about nicotine?
This bastard is the king of paradox.
Usually, when receptors are constantly stimulated by an agonist, they get tired and burn out.
This is called downregulation.
Dopamine receptors are a prime example.
It’s why junkies need to shove in more and more drugs over time.
But nicotinic cholinergic receptors, these guys are the complete opposite.
When chronically stimulated by the agonist nicotine, upregulation actually occurs—their numbers increase.
This is why neuroscientists call it a paradox.
The exact reason is still debated, but the fact remains.
Now the picture is clear, right?
Whether you lock the receptor’s door with an antagonist and starve it, or you brutally beat the receptor with nicotine, our body’s final reaction is the same.
“Receptor Upregulation”
It erects more antennas.
In the end, the true core of the antidepressant effect is likely this “upregulated state” itself, according to my theory.
Nicotine or antagonist are just methods.
The destination is the same.
There’s one more crucial difference here.
Remember what I said earlier?
Acetylcholine is the dumb infantry.
It beats all cholinergic receptors non-selectively, ultimately exhausting the entire system and leading it towards downregulation.
In contrast, nicotine selectively targets only nicotinic receptors, paradoxically inducing upregulation.
One makes the system dull, the other makes the system more sensitive.
So of course, the results have to be different.
The riddle is solved.
Whining about it being a contradiction based only on the superficial action (stimulation vs. blockade) is something only amateurs do.
You have to look at what final change that action induces in the system.
Nicotine and antagonists take different paths, but they meet at the same summit: receptor upregulation.
The real pros look not at the name of the drug, but at the operating principle of the system that the drug is messing with.
Reference Papers
1. Nicotine’s Paradoxical Upregulation
Nicotine is the guy that beats the receptors, but the more they get hit, the more receptors (antennas) increase. This crazy bastard.
This is called “paradoxical upregulation.”
The true cause of the antidepressant effect is likely this increased number of antennas—the upregulated state itself.
Nicotinic Acetylcholine Receptors and Depression: A Review of the Preclinical and Clinical Literature
(Nicotinic Acetylcholine Receptors and Depression: A Review of the Preclinical and Clinical Literature)
https://pmc.ncbi.nlm.nih.gov/articles/PMC5316481/
2. Long-Term Effects of Cholinergic Antagonists
Antagonists like scopolamine block the receptors.
But the real drug effect continues even after the drug is gone from the body.
This isn’t simple blockade; it’s the brain screaming “Give me the signal!” and rewiring its own circuits.
Here too, the core is ultimately receptor upregulation.
Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review
(Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review)
https://pmc.ncbi.nlm.nih.gov/articles/PMC3478904/
